Accelerated recovery of irradiation-induced bone marrow depression by fibroblast-mediated interleukin 6 gene therapy in combination with bone marrow transplantation in mice

Transplantation

Volumn 65, Issue 3, 1998, Pages 325-331

  Cao, Xuetao ^a   Cai, Rong ^a   Ju, Dian Wen ^a   Tao, Qun ^a   Yu, Yizhi ^a   Wang, Jianli ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; NEOMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW SUPPRESSION; BONE MARROW TRANSPLANTATION; CELL STRAIN 3T3; COLONY FORMING UNIT GM; COLONY FORMING UNIT M; COLONY FORMING UNIT S; CONTROLLED STUDY; FEMALE; FIBROBLAST; GAMMA IRRADIATION; GENE TARGETING; GENE THERAPY; LEUKOCYTE COUNT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE COUNT;

3T3 CELLS; ANIMALS; BONE MARROW; BONE MARROW TRANSPLANTATION; COBALT RADIOISOTOPES; COMBINED MODALITY THERAPY; FEMALE; FIBROBLASTS; GAMMA RAYS; GENE THERAPY; HUMANS; INTERLEUKIN-6; MALE; MICE; MICE, INBRED BALB C; SURVIVAL RATE; TRANSFECTION; TRANSPLANTATION, ISOGENEIC;

EID: 0032519662     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199802150-00006     Document Type: Article

References (51)

1. Van Snick J. Interleukin 6: an overview. Annu Rev Immunol 1990; 8: 253.
2. Kerst JM, Slaper-Cortenbach IC, Van Der Schoot CE, et al. Interleukin-6 is a survival factor for committed myeloid progenitor cells. Exp Hematol 1993; 21: 1550.
3. Wong GG, Witek-Giannotti JS, Temple PA, et al. Stimulation of murine hematopoietic colony formation by IL-6. J Immunol 1988; 140: 3040.
4. Kishimoto T. The biology of interleukin 6. Blood 1989; 74: 1.
5. Ishibashi T, Kimura H, Uchida T, et al. Human interleukin-6 is a direct promoter of maturation of megakaryocytes in vitro. Proc Natl Acad Sci USA 1989; 86: 5953.
6. Farese AM, Williams DE, Seiler FR, Macvittie TJ. Combination protocols of cytokine therapy with interleukin-3 and granulocyte-macrophage colony-stimulating factor in a primate model of radiation-induced marrow aplasia. Blood 1993; 82: 3012.
7. Zeidler C, Kanz L, Hurkuck F, et al. In vivo effects of interleukin-6 on thrombopoiesis in healthy and irradiated primates. Blood 1992; 80: 2740.
8. Patchen ML, Macvittie TJ, Williams JL, et al. Administration of interleukin-6 stimulates multilineage hematopoiesis and accelerates recovery from radiation-induced hematopoietic depression. Blood 1991; 77: 472.
9. Herodin F, Mestries JC, Janodet D, et al. Recombinant glycosylated human interleukin-6 accelerates peripheral blood platelet count recovery in radiation-induced bone marrow depression in baboons. Blood 1992; 80: 688.
10. Okano A, Suzuki C, Takatsuki F, et al. Effects of interleukin-6 on hematopoiesis in bone marrow-transplanted mice. Transplantation 1989; 47: 738.
11. Givon T, Revel M, Slavin S. Potential use of interleukin-6 in bone marrow transplantation: effects of recombinant human interleukin-6 after syngeneic and semiallogeneic bone marrow transplantation in mice. Blood 1994; 83: 1690.
12. Anderson WF. Gene therapy for cancer. Hum Gene Ther 1994; 5: 1.
13. Porgador A, Feldman M, Eisenbach L. Immunotherapy of tumor metastasis via gene therapy. Nat Immunol 1994; 13: 113.
14. Pardoll DM. Cancer vaccines. Immunol Today 1993; 14: 310.
15. Ram Z, Culver KW, Walbridge S, et al. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res 1993; 53: 83.
16. Blankenstein T, Qin Z. Cancer vaccine in gene therapy. Gene Ther 1996; 3: 95.
17. Selden RF, Skoskiewicz MJ, Howie KB, et al. Implantation of genetically engineered fibroblasts into mice: implications for gene therapy. Science 1987; 236: 714.
18. Veelken, Jesuiter H, Mackensen A, et al. Primary fibroblasts from human adults as target cells form ex vivo transfection and gene therapy. Hum Gene Ther 1996; 5: 1203.
19. Click RP, Lichtor T, Kim TS, et al. Fibroblasts genetically engineered to secrete cytokines suppress tumor growth and induce antitumor immunity to a murine glioma in vivo. Neurosurgery 1995; 36: 548.
20. Elder EM, Lotze MT, Whiteside TL. Successful culture and selection of cytokine gene-modified human dermal fibroblasts for the biologic therapy of patients with cancer. Hum Gene Ther 1996; 7: 479.
21. Tahara H, Lotze MT, Robbins PD, et al. IL-12 gene therapy using direct injection of tumors with genetically engineered autologous fibroblasts. Hum Gene Ther 1995; 6: 1607.
22. Lotze MT, Rubin JT. The therapy of cancer: a pilot study of IL-4-gene-modified fibroblasts admixed with autologous tumor to elicit an immune response. Hum Gene Ther 1994; 5: 41.
23. Sobol RE, Royston I. Injection of colon carcinoma patients with autologous irradiated tumor cells and fibroblasts genetically modified to secret interleukin-2 (IL-2): a phase I study. Hum Gene Ther 1995; 6: 195.
24. Tani K, Ozawa K, Ogura H, et al. Implantation of fibroblasts transfected with human granulocyte colony-stimulating factor cDNA into mice as a model of cytokine-supplement gene therapy. Blood 1989; 74: 1274.
25. Cao X, Zang W, Gu S, et al. Experimental study on the augmentation of host immune functions by fibroblast-mediated human interleukin-6 gene therapy. Chin J Immunol 1994; 10: 8.
26. Galmiche MC, Vogel CA, Delaloye AB, et al. Combined effects of interleukin 3 and interleukin 11 on hematopoiesis in irradiated mice. Exp Hematol 1996; 24: 1298.
27. Neben TY, Loebelenz J, Hayes L, et al. Recombinant human interleukin 11 stimulates megakaryocytopoiesis and peripheral platelets in normal and splenectomized mice. Blood 1993; 81: 901.
28. Nothdurft W, Selig C, Fliedner TM, et al. Hematological effects of rhGM-CSF in dogs exposed total body irradiation with a dose of 2.4 Gy. Int J Radiat Biol 1992; 61: 519.
29. Macvittie TJ, Monroy R, Patchen ML, Souza LM. Therapeutic use of recombinant human G-CSF (rhG-CSF) in a canine model of sublethal and lethal whole-body irradiation. Int J Radiat Biol 1990; 57: 723.
30. Zsebo KM, Smith KA, Hartley CA, et al. Radioprotection of mice by recombinant rat stem cell factor. Proc Natl Acad Sci USA 1992; 89: 9464.
31. Drize N, Chertkov J, Samoilina N, Zander A. Effects of cytokine treatment (granulocyte colony stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice. Exp Hematol 1996; 24: 816.
32. Wrighton NC, Farrell FX, Chang R, et al. Small peptides as potent mimetics of the protein hormone erythropoietin. Science 1996; 273: 458.
33. Neta R, Douches S, Oppenheim JJ. Interleukin 1 is a radioprotector. J Immunol 1980; 136: 2483.
34. Oppenheim JJ, Neta R, Tiberghien P, et al. Interleukin 1 enhances survival of lethally irradiated mice treated with allogeneic bone marrow cells. Blood 1989; 74: 2257.
35. Tiberghien P, Laithier V, Mabed M, et al. Interleukin 1 administration before lethal irradiation and bone marrow transplantation: early transient increase of leukocyte, erythrocyte, and platelet recovery. Blood 1993; 81:1933.
36. Du XX, Keller D, Maze R, Williams DA. Comparative effects of in vivo treatment using interleukin 11 and stem cell factor on reconstruction in mice after bone marrow transplantation Blood 1993; 82: 1016.
37. Du XX, Neben T, Doldman S, Williams DA. Effects of recombinant human interleukin 11 on hematopoietic reconstruction in transplant mice: acceleration of recovery of peripheral blood neutrophils and platelets. Blood 1993; 81: 27.
38. Ohwada A, Rafii S, Moore MSA, Crystal RG. In vivo adenovirus vector-mediated transfer of the human thrombopoietin cDNA maintains platelet levels during radiation- and chemotherapy-induced bone marrow suppression. Blood 1996; 88: 778.
39. Sheridan WP, Morstyn G, Wolf M, et al. Granulocyte colony stimulating factor and neutrophil recovery after high dose chemotherapy and autologous bone marrow transplantation. Lancet 1989; 2: 891.
40. Brandt SJ, Peters WP, Atwater SK, et al. Effects of recombinant human granulocyte-macrophage colony stimulating factor on hematopoietic reconstruction after high dose chemotherapy and autologous bone marrow transplantation. N Engl J Med 1988; 318: 869.
41. Albin N, Douay L, Fouillard L, Laporte JP, et al. In vivo effects of GM-CSF and IL-3 on hematopoietic cell recovery in bone marrow and blood after autologous transplantation with mafosfamide-purged marrow in lymphoid malignancies. Bone Marrow Transplant 1994; 14: 253.
42. Geissler K, Valent P, Mayer P, et al. Recombinant human interleukin-3 expands the pool of circulating hematopoietic progenitor cells in primate: synergism with recombinant human granulocyte/macrophage colony-stimulating factor. Blood 1990; 75: 2305.
43. Nand S, Sosman J, Godwin JE, Fisher RI. A phase I/II study of sequential interleukin-3 and granulocyte-macrophage colony-stimulating factor in myelodysplastic syndromes. Blood 1994; 83: 357.
44. Carraciolo D, Clark CS, Rovera G. Human interleukin-6 supports granulocytic differentiation of hematopoietic progenitor cells and acts synergistically with GM-CSF. Blood 1989; 73: 666.
45. Nebber J, Rosenberg SA. Phase I studies of the pharmacokinetic, toxicities and biological effects of interleukin-6 in patients with refractory advanced malignancies. J Immunother 1993; 13: 74.
46. Hill GR, Inder A, Patton WN, Hart DN. High dose therapy and autologous bone marrow versus blood cell rescue. N Z Med J 1996; 109: 45.
47. Laterveer L, Zijlmans JM, Liehl E, et al. Accelerated platelet reconstitution following transplantation of bone marrow cells derived from IL-6-treated donor mice. Ann Hematol 1996; 73: 239.
48. Lazarus HM, Winton EF, Williams SF, et al. Phase I multicenter trial of interleukin 6 therapy after autologous bone marrow transplantation in advanced breast cancer. Bone Marrow Transplant 1995; 15: 935.
49. Wang J, Cao X, Zhang W, et al. Treatment of leukemia with fibroblast-mediated interferon alpha gene therapy alone or in combination with doxorubicin. Leuk Res 1996; 20: 379.
50. Cao X, Zhang W, Tao Q, et al. Augmentation of immunity and antitumor effects of fibroblast-mediated IL-2 gene therapy. Natl Med J China 1995; 75: 521.
51. Yu Y, Cao X, Zhang W, et al. Establishment of fibroblast-mediated interleukin 4 gene therapy. Chin J Microbiol Immunol 1994; 14: 410.